Showing results (241-250 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|November 23, 2014
Single-nucleotide polymorphism rs41736 located in MET was significantly associated with prognosis of small cell lung cancer patientsXu Cao, Xuan Hong, Xiaoli Jia, et al.
Medical Oncology (Northwood, London, England)|November 23, 2014
Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitroZhonglu Yang, Zhiyi Wu, Tao Liu, et al.
Medical Oncology (Northwood, London, England)|October 15, 2015
IL-37 mediates the antitumor activity in renal cell carcinomaYazhuo Jiang, Yili Wang, Liang Liang, et al.
Medical Oncology (Northwood, London, England)|October 24, 2015
DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1Alina Rosinha, Joana Assis, Francisca Dias, et al.
Medical Oncology (Northwood, London, England)|December 8, 2014
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancerRanhua Cao, Shuai Zhang, Dedong Ma, et al.
Medical Oncology (Northwood, London, England)|November 1, 2015
The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116Daiva Dabkeviciene, Violeta Jonusiene, Vilmante Zitkute, et al.
Medical Oncology (Northwood, London, England)|November 14, 2015
Expressional profiles of transcription factors in the progression of Helicobacter pylori-associated gastric carcinoma based on protein/DNA array analysisTing-Zi Hu, Li-Hua Huang, Can-Xia Xu, et al.
Medical Oncology (Northwood, London, England)|March 23, 2016
Identification of allelic expression imbalance genes in human hepatocellular carcinoma through massively parallel DNA and RNA sequencingQiudao Wang, Yan An, Qing Yuan, et al.
Medical Oncology (Northwood, London, England)|October 27, 2015
Continuing EGFR-TKI treatment in combination with super-selective arterial infusion chemotherapy beyond disease progression for patients with advanced EGFR-mutant non-small cell lung cancerHuiwei Qi, Sen Jiang, Dong Yu, et al.
Medical Oncology (Northwood, London, England)|August 28, 2015
Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancerYasuyoshi Miyata, Akihiro Asai, Kensuke Mitsunari, et al.
Pageof 570